| scholarly article | Q13442814 |
| P2093 | author name string | Florin Vaida | |
| Beibei Xu | |||
| Loren K Mell | |||
| James D Murphy | |||
| Daniel P Triplett | |||
| Lindsay Hwang | |||
| Brent S Rose | |||
| Ruben Carmona | |||
| Kaveh Zakeri | |||
| Casey W Williamson | |||
| Garrett Green | |||
| Hanjie Shen | |||
| Rohan Verma | |||
| Sachin Gulaya | |||
| P2860 | cites work | Human papillomavirus and survival of patients with oropharyngeal cancer. | Q27851567 |
| Comprehensive genomic characterization of head and neck squamous cell carcinomas | Q28256121 | ||
| Smoking and mortality--beyond established causes | Q28256793 | ||
| Development of a comorbidity index using physician claims data | Q30623996 | ||
| Cumulative incidence in competing risks data and competing risks regression analysis | Q31095948 | ||
| Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study | Q34343656 | ||
| Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study | Q34506853 | ||
| Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease. | Q34990687 | ||
| Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy | Q35120228 | ||
| Prognostic importance of comorbidity in a hospital-based cancer registry | Q35783153 | ||
| Time-dependent predictive accuracy in the presence of competing risks | Q35881672 | ||
| The use and interpretation of competing risks regression models | Q35894830 | ||
| Competing risks to breast cancer mortality in Catalonia. | Q37085929 | ||
| Choice and interpretation of statistical tests used when competing risks are present | Q37124914 | ||
| Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer | Q37140722 | ||
| Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study | Q38431287 | ||
| Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification | Q43674377 | ||
| Validated competing event model for the stage I-II endometrial cancer population | Q43733348 | ||
| Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients | Q43776310 | ||
| Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer. | Q44378219 | ||
| Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy | Q44812851 | ||
| Population and personalized medicine in the modern era. | Q45370345 | ||
| Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. | Q45942167 | ||
| Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer | Q46066104 | ||
| Predictors of competing mortality in advanced head and neck cancer | Q46215317 | ||
| Predictors of competing mortality in early breast cancer | Q46559589 | ||
| Overtreatment of men with low-risk prostate cancer and significant comorbidity | Q46832308 | ||
| More on Cetuximab in Head and Neck Cancer | Q56775178 | ||
| Radical prostatectomy versus watchful waiting in early prostate cancer | Q57137210 | ||
| Population-Based Study of Competing Mortality in Head and Neck Cancer | Q62071387 | ||
| Pitfalls of Using Composite Primary End Points in the Presence of Competing Risks | Q62071396 | ||
| Applications of crude incidence curves | Q68138066 | ||
| BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer | Q73328358 | ||
| Risk models and patient-centered evidence: should physicians expect one right answer? | Q83916433 | ||
| Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer | Q87520011 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1270-1277 | |
| P577 | publication date | 2016-02-16 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events | |
| P478 | volume | 34 |
| Q49493715 | A Risk-benefit Assessment Approach to Selection of Adjuvant Chemotherapy in Elderly Patients with Early Breast Cancer: A Mini Review |
| Q92108706 | Claims-Based Approach to Predict Cause-Specific Survival in Men With Prostate Cancer |
| Q91965123 | Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy |
| Q91741812 | Competing risk nomogram to predict cancer-specific survival in esophageal cancer during the intensity-modulated radiation therapy era: A single institute analysis |
| Q97538060 | Development of a predictive nomogram for cause-specific mortality in surgically resected early-stage oesophageal cancer: a Surveillance, Epidemiology, and End Results (SEER) analysis |
| Q47877600 | Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making? |
| Q40377554 | Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis |
| Q42322235 | Moving beyond disease-focused decision making: understanding competing risks to personalize lung cancer treatment for older adults |
| Q92798993 | Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma |
| Q100446919 | Predictive classifier for intensive treatment of head and neck cancer |
| Q91734073 | Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis |
| Q28076894 | Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck |
| Q92036707 | Undertreatment of women with locoregionally advanced head and neck cancer |
Search more.